Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2024 · 10-Q
Revenue$20.16M$20.16M+28.0% vs Q2 2023 Net Income-$3.50M-$3.50MN/M vs Q2 2023 EPS Diluted-$0.41-$0.41N/M vs Q2 2023 Gross Profit$18,150,137+33.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,411,930N/M Free Cash Flowderived-$1,470,692N/M Margins · derivedGross margin90.0%+3.9 pt vs Q2 2023
Operating margin-14.3%−2.5 pt vs Q2 2023
Net margin-17.4%−5.8 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 12, 2024 · 43 d after period end